Machida Takahiro, Katayama Hinako, Yoshida Osamu, Watanabe Akihisa
Orthopaedics, Machida Orthopaedics, Kochi, JPN.
Rehabilitation, Machida Orthopaedics, Kochi, JPN.
Cureus. 2021 Dec 16;13(12):e20456. doi: 10.7759/cureus.20456. eCollection 2021 Dec.
Chronic postsurgical pain (CPSP) is a common complication of surgery. We report that a patient with CPSP after open reduction and internal fixation (ORIF) had pain relief with duloxetine, and that the conditioned pain modulation (CPM) efficiency may predict the efficacy of duloxetine. A 54-year-old woman with CPSP after ORIF due to proximal humeral fracture was presented to our orthopedic clinic one month after surgery. Despite several analgesics, she still had pain three months after surgery, pain during activity was 74 on the visual analogue scale (VAS), 16 on the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), 18 on the PainDETECT questionnaire, and CPM efficiency was -5.7%. The patient was treated with duloxetine, starting at 20mg/day and increasing every week. Three months after starting duloxetine, pain on the VAS was 18, ASES was 61, PainDETECT questionnaire was 6, and CPM efficiency was -39.8%. The dose of duloxetine was decreased every week and then withdrawn. Neuropathic pain may be involved even in patients with CPSP after ORIF, and duloxetine may be efficacious in such cases. CPM testing may provide useful information for clinicians in selecting appropriate drugs and in determining when to withdraw drugs.
慢性术后疼痛(CPSP)是手术常见的并发症。我们报告了1例切开复位内固定术(ORIF)后发生CPSP的患者使用度洛西汀后疼痛缓解,且条件性疼痛调制(CPM)效率可能预测度洛西汀的疗效。1例54岁女性因肱骨近端骨折行ORIF术后发生CPSP,术后1个月到我们骨科门诊就诊。尽管使用了多种镇痛药,术后3个月她仍有疼痛,活动时疼痛在视觉模拟量表(VAS)上为74分,在美国肩肘外科医师协会标准化肩部评估表(ASES)上为16分,在疼痛检测问卷上为18分,CPM效率为-5.7%。患者接受度洛西汀治疗,起始剂量为20mg/天,每周增加剂量。开始使用度洛西汀3个月后,VAS疼痛评分为18分,ASES评分为61分,疼痛检测问卷评分为6分,CPM效率为-39.8%。度洛西汀剂量每周递减然后停药。即使是ORIF术后发生CPSP的患者也可能涉及神经性疼痛,度洛西汀在这类病例中可能有效。CPM测试可为临床医生选择合适药物及确定停药时机提供有用信息。